We describe novel murine immunocompetent glioblastoma stem cell (GSC) lines derived from Nestin-CreERT2 Quaking (QKI)L/L; P53L/L; PTENL/L (QPP) mice [5] and determine their sensitivities to immunotherapies. Here, NES is linked to glioblastoma.